Brief: 10X Wins Injunction From Unified Patent Court Banning Sales Of Nanostring's CosMx Products In Europe
Sept 19 (Reuters) - 10x Genomics, Inc.:
* 10X WINS INJUNCTION FROM UNIFIED PATENT COURT BANNING
SALES OF
NANOSTRING'S COSMX PRODUCTS IN EUROPE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences